Synopsis: In a recently issued final written decision, the Patent Trial and Appeal Board (the “Board”) found all challenged ...

Although the comparison between Claim 1 and Claim 2 clearly shows the feature that would make the claim patent-eligible, Example 49 may not have much value in real-world patent applications.

Monday, three Big Pharma leaders took center stage and addressed concerns about future patent expirations head-on. In separate presentations, the CEOs of Bristol Myers Squibb, Pfizer and Merck ...

Titin is a protein in muscles, has the biggest chemical formula. It’s very large and helps muscles stretch and move properly. Tap to read in detail. The systematic name of Titin has over 180,000 ...

For example, a company may have a very high current ratio, but its accounts receivable may be very aged, perhaps because its customers pay slowly, which may be hidden in the current ratio.